Business ❯ Healthcare ❯ Pharmaceuticals

Cancer Treatment

Keytruda Clinical Trials Bladder Cancer Anktiva Isotopes Production Springworks Therapeutics Clinical Research Radioligand Therapy Bispecific Antibodies Summit Therapeutics CAR-T Therapy Immuno-Oncology Botensilimab and Balstilimab CAR T-cell Therapy Acquisitions

Novartis Breaks Ground on Texas Plant to Speed Radioligand Cancer Drug Delivery

The Denton site extends a $23 billion U.S. buildout designed to place short‑lived therapies closer to patients.

TerraPower Isotopes Breaks Ground on $450 Million Actinium-225 Plant in Philadelphia

Sandisk Soars on NAND Boom Ahead of Nasdaq-100 Entry and Earnings Update

Merck Beats in Q3 on Keytruda, Narrows 2025 Outlook as Gardasil Slumps in China

Merck Launches $3 Billion Cost-Optimization Program Following Q2 Revenue Miss